FIELD: medicine; therapy and oncology.
SUBSTANCE: group of inventions is intended for the treatment or prevention of non-melanoma skin cancer. For the production of an oral pharmaceutical composition, cholecalciferol (compound D3) and/or its derivatives are used. An oral pharmaceutical composition containing synergistic amounts of Compound D3 and/or derivatives thereof is used to treat or prevent non-melanoma skin cancer. The said composition may also contain vitamin K2 and/or magnesium or its salts.
EFFECT: use of the group of inventions provides effective treatment or prevention of non-melanoma skin cancer.
3 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM | 2013 |
|
RU2666995C2 |
APPLICATION OF PHOTOTROPHIC BACTERIA RHODOBACTER CAPSULATUS PG LIPOPOLISACCHARIDE AS FACTOR AFFECTING DIFFERENTIATION ACTIVITY OF 1ALFA,25-DIHYDROXYVITAMIN D3 | 2016 |
|
RU2642309C1 |
METHOD OF PRODUCING AND DETERMINING SPECIFIC ACTIVITY OF MACROPHAGE ACTIVATION FACTOR GcMAF | 2023 |
|
RU2823530C1 |
METHOD FOR PREVENTION OF AGGRAVATED RECURRENT RHINOSINUSITIS | 2013 |
|
RU2562537C2 |
METHOD OF TREATING (THERAPY OF) COMPENSATED NON-SPECIFIC CHRONIC TONSILLITIS | 2012 |
|
RU2510749C1 |
METADICHOL-LIQUID AND GEL NANO-DRUGS | 2014 |
|
RU2736752C2 |
METHOD OF COMPLEX PATHOGENETIC THERAPY OF ACUTE FORMS OF VIRAL HEPATITIS B AND MIXED HEPATITES (B+C, B+D, B+C+D) | 2010 |
|
RU2440128C1 |
METADIHOL® - LIQUID AND GEL NANOLARTICAL PREPARATIONS | 2014 |
|
RU2631600C2 |
DERIVATIVES OF VITAMIN D | 1993 |
|
RU2114825C1 |
METHOD FOR PREVENTING BENIGN PROSTATE HYPERPLASIA IN MALE PATIENTS DISTINGUISHED BY PARTIAL ANDROGEN AGE-SPECIFIC DEFICIENCY (PADAM) | 2002 |
|
RU2236175C2 |
Authors
Dates
2023-04-17—Published
2019-08-22—Filed